Description

Mounjaro® (Tirzepatide) Weight Loss Shots

Tirzepatide is also approved for chronic weight management under the brand Zepbound® for eligible adults with obesity or overweight and certain weight-related medical conditions. By helping reduce appetite and increasing feelings of fullness, tirzepatide can support significant weight loss when combined with a healthy diet and regular physical activity.

How Mounjaro Works

Mounjaro is the first medication in its class to activate both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual-action mechanism helps:

• Reduce appetite and food cravings
• Increase feelings of fullness after meals
• Slow stomach emptying
• Improve blood sugar regulation
• Support clinically meaningful weight loss under medical supervision

Key Benefits

• Supports substantial weight loss as part of a comprehensive weight management program
• Helps reduce hunger and calorie intake
• Once-weekly, easy-to-use injection
• Improves blood sugar control in adults with type 2 diabetes
• May improve certain metabolic health markers alongside healthy lifestyle changes

Who May Be Eligible?

Tirzepatide for chronic weight management may be appropriate for adults who:

• Have a BMI of 30 kg/m² or greater, or
• Have a BMI of 27 kg/m² or greater with at least one weight-related condition, such as hypertension, type 2 diabetes, or dyslipidemia.

Treatment should always be prescribed and monitored by a licensed healthcare professional.

Common Side Effects

The most common side effects include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Stomach pain
• Indigestion
• Decreased appetite
• Injection site reactions

These side effects are often mild to moderate and may improve as the body adjusts to treatment.

Important Safety Information

Mounjaro is not appropriate for everyone. It should not be used by individuals with:

• A personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• A known allergy to tirzepatide or any of its ingredients

Seek immediate medical attention if you experience severe abdominal pain, signs of pancreatitis, serious allergic reactions, or significant vision changes.

Storage

Store unused Mounjaro pens in a refrigerator at 36°F–46°F (2°C–8°C). Do not freeze. Follow the manufacturer’s storage instructions after dispensing and before use.

Disclaimer

Mounjaro is a prescription-only medication and should only be used under the supervision of a licensed healthcare provider. Individual weight loss results vary and are best achieved when medication is combined with healthy nutrition, regular physical activity, and ongoing medical follow-up.

Mounjaro weight loss shots, Mounjaro injection, tirzepatide weight loss, prescription weight loss medication, GLP-1 and GIP receptor agonist, weekly weight loss injection, medically supervised weight loss, tirzepatide injections, obesity treatment, type 2 diabetes medication, prescription appetite suppressant, chronic weight management, Zepbound, weight loss therapy.